pDNA intralesional cancer vaccine

· TuHURA Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pDNA intralesional cancer vaccine, covering 2022-08-08 to 2022-08-08. Get the full timeline:

Most recent: Clinical Trial Update: pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma [EARLY_Phase 1]